Acutaas Chemicals LtdPharmaceuticalsINE00FF01025Consolidated₹3438.15+122.55 (+3.70%)Jun-26
Valuation
Market Cap₹28.17K Cr
TTM PE94.85x
Forward PE83.60x
PEG26.13
Book Value₹146.83
P/B23.43x
TTM EPS₹36.27
Fwd EPS₹41.15
TTM Revenue₹1.24K Cr
TTM PAT₹297.08 Cr
TTM EBITDA₹399.37 Cr
TTM EBIT₹373.02 Cr
Last Qtr PAT₹74.99 Cr
Last Qtr EBITDA₹113.06 Cr
Last Qtr EBIT₹103.24 Cr
Profitability
ROE24.71%
ROCE33.54%
TTM NPM24.03%
TTM EBITDA %32.30%
Curr OPM22.62%
Last OPM26.70%
Curr NPM—
Last NPM—
Curr EPS₹9.07
Last EPS₹12.97
Balance sheet
Equity₹40.93 Cr
Reserve₹1.16K Cr
Total Debt₹6.17 Cr
D/E0.01x
Interest %1.52%
Curr Interest₹1.14 Cr
Price / range
Close₹3440.30
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+3.78%
1W+1.80%
1M+1.44%
3M+9.63%
6M+21.58%
1Y+204.25%
2Y+334.70%
3Y+428.71%
5Y—
Diwali+204.25%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits